| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | PetVivo Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.10. | Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors | 1 | GlobeNewswire (USA) | ||
| 16.10. | PetVivo Holdings, Inc.: PetVivo Animal Health, Inc. Enters Vendor Partner Agreement with Veterinary Growth Partners to Expand Access to Innovative Veterinary Therapeutics | 3 | GlobeNewswire (USA) | ||
| 09.10. | New to The Street Signs PetVivo Holdings Inc. to a 12-Month National Media Campaign | 199 | ACCESS Newswire | Partnership Includes Long-Form Broadcast Interviews, National TV Commercials, Outdoor Billboards, and Accredited Investor Events NEW YORK CITY, NEW YORK / ACCESS Newswire / October 9, 2025 / New to... ► Artikel lesen | |
| 30.09. | PetVivo Holdings wandelt Schulden von 2 Millionen US-Dollar in Eigenkapital um | 1 | Investing.com Deutsch | ||
| 30.09. | PetVivo Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| PETVIVO Aktie jetzt für 0€ handeln | |||||
| 25.09. | PetVivo Holdings, Inc.: PetVivo Animal Health Expands Veterinary Education with New RACE-Approved CE Courses on Osteoarthritis and Regenerative Therapies | 1 | GlobeNewswire (USA) | ||
| 02.09. | PetVivo Holdings, Inc.: PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITED | 2 | GlobeNewswire (USA) | ||
| 15.08. | PetVivo Holdings GAAP EPS of -$0.09 | 1 | Seeking Alpha | ||
| 14.08. | PetVivo Holdings, Inc.: PetVivo Reports Fiscal Q1 2026 Results | 244 | GlobeNewswire (Europe) | MINNEAPOLIS, MN, US, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX: PETV; OTC ID: PETVW), a leading biomedical... ► Artikel lesen | |
| 09.08. | New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals | 830 | ACCESS Newswire | NEW YORK CITY, NY / ACCESS Newswire / August 9, 2025 / New to The Street, one of the nation's longest-running business television brands, will broadcast Show #683 on Bloomberg today at 6:30 PM EST.... ► Artikel lesen | |
| 01.08. | New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Tea | 460 | ACCESS Newswire | Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Team NEW YORK CITY, NEW YORK / ACCESS Newswire / August 1, 2025 / New to The Street, the nation's... ► Artikel lesen | |
| 30.07. | PetVivo Holdings, Inc.: PetVivo Holdings Inc. to Trade on OTCQX Best Market | 206 | GlobeNewswire (Europe) | MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX PETV; OTCID: PETVW) working in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo"... ► Artikel lesen | |
| 30.07. | OTC Markets Group Welcomes PetVivo Holdings Inc. to OTCQX | 149 | GlobeNewswire (Europe) | NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced PetVivo Holdings... ► Artikel lesen | |
| 10.07. | PetVivo Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 30.06. | PetVivo Holdings GAAP EPS of -$0.39, revenue of $1.1M | 1 | Seeking Alpha | ||
| 30.06. | PetVivo Holdings, Inc.: PetVivo Reports Fiscal 2025 Results | 325 | GlobeNewswire (Europe) | MINNEAPOLIS, MN, US, June 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. and its wholly-owned subsidiary PetVivo Animal Health, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company... ► Artikel lesen | |
| 30.06. | PetVivo Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 2 | SEC Filings | ||
| 24.06. | PetVivo Holdings schließt Vorzugsaktienangebot in Höhe von 5 Millionen US-Dollar ab | - | Investing.com Deutsch | ||
| 24.06. | PetVivo Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,290 | -1,58 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Analyst David Adlington stellte seine Schätzungen... ► Artikel lesen | |
| FRESENIUS | 48,250 | +0,42 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 49,10 Euro auf "Overweight" belassen. Analyst David Adlington glich seine Schätzungen am Donnerstagabend... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,040 | +0,67 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,490 | -3,31 % | Alignment Healthcare: Goldman Sachs erhöht Kursziel auf 22 US-Dollar | ||
| PROCEPT BIOROBOTICS | 31,300 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 25,120 | -1,41 % | Aixtron, Formycon, Gerresheimer, HelloFresh, Hugo Boss, Ströer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,760 | -2,43 % | Carl Zeiss Meditec-Aktie sorgt für Jubel - neue Signale wecken frische Kursfantasie! | ||
| BILLIONTOONE | 109,69 | 0,00 % | BillionToOne, Inc.: BillionToOne Announces Pricing of Upsized Initial Public Offering | MENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to... ► Artikel lesen | |
| OTTOBOCK | 68,00 | -3,75 % | Ottobock-Aktie zieht an - Anleger sehen jetzt wieder echtes Potenzial! | ||
| LIFESTANCE HEALTH GROUP | 6,260 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| GENEDX | 139,02 | +1,36 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,000 | -4,19 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GOODRX | 3,160 | 0,00 % | GoodRx won't be participating with TrumpRx: report | ||
| BRIGHTSPRING HEALTH SERVICES | 32,580 | 0,00 % | BrightSpring Health Services GAAP EPS of $0.17 misses by $0.15, revenue of $3.33B misses by $20M | ||
| CLEARPOINT NEURO | 18,260 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Agreement to Acquire IRRAS | Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment... ► Artikel lesen |